- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01409902
Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
April 22, 2013 updated by: University of South Florida
The main objective of the study is to assess the effectiveness of the sheathed speculum in providing adequate visualization and access to the cervix in patients with excessive vaginal tissue.
The secondary objective is to rate the patient's comfort evaluation during the sheathed speculum examination.
Study Overview
Status
Completed
Conditions
Detailed Description
This is a descriptive clinical trial designed to assess the efficacy of a sheathed speculum in providing adequate visualization and access to the cervix in women with excessive vaginal tissue.
Eligible, consented subjects who fail their initial speculum examination (because their cervix is not visualized due to the collapse of loose lateral vaginal walls) will have a sheathed speculum examination instead of the standard-of-care exam whereby the clinician fabricates a solution at the bedside (condom with tip cut placed on speculum, concomitantly using an additional instrument like a lateral-wall retractor, glove with tip of thumb placed over the speculum, using the largest speculum available)
Study Type
Observational
Enrollment (Actual)
38
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33549
- USF STC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
excessive vaginal tissue
Description
Inclusion Criteria:
- Age 18 to 64 years
- BMI greater than 30 (or see next line)
- Collapsing vaginal tissue preventing the visualization of the cervix (meeting this criterion in the absence of a BMI >30 would also qualify the patient for the study).
- Able to provide written informed consent
Exclusion Criteria:
- Patients unwilling to participate in the study or provide consent Presence of significant acute pelvic pain syndromes (ie exacerbation of dyspareunia, chronic pelvic pain or pelvic floor dysfunction, atrophic vaginitis, interstitial cystitis, endometriosis) which, in the opinion of the examining clinician, could potentially confound the patient's responses to the questionnaire
- Presence of active genital herpes
- Presence of significant condyloma acuminata (may be an investigator decision)
- Any other patient deemed inappropriate for the study by the consenting or examining investigator.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of patients with adequate visualization and access to cervix or vaginal vault
Time Frame: At time of speculum exam
|
At time of speculum exam
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Erich Wyckoff, M, University of South Florida
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
August 2, 2011
First Submitted That Met QC Criteria
August 3, 2011
First Posted (Estimate)
August 4, 2011
Study Record Updates
Last Update Posted (Estimate)
April 23, 2013
Last Update Submitted That Met QC Criteria
April 22, 2013
Last Verified
April 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 105827
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaginal Prolapse
-
The Methodist Hospital Research InstituteUnknownVaginal Vault Prolapse | Post-Hysterectomy Vaginal Vault Prolapse | Prolapse, VaginalUnited States
-
Ain Shams UniversityCompletedUterovaginal and Vaginal Vault ProlapseEgypt
-
Kaiser PermanenteMassachusetts General HospitalUnknownProlapse of Vaginal Vault After HysterectomyUnited States
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
-
University of SalfordUnknownPelvic Organ Prolapse | Cystocele | Uterine Prolapse | Rectocele | Anterior Wall; Prolapse, Vaginal | Posterior Wall; Prolapse, Vaginal | Vault Prolapse, VaginalUnited Kingdom
-
Centre Hospitalier Universitaire de NīmesCompletedVaginal ProlapseFrance
-
Azienda Ospedaliera Cardinale G. PanicoCompletedPelvic Organ Prolapse | Posterior Vaginal Wall ProlapseItaly
-
National Taiwan University HospitalCompletedVault Prolapse, Vaginal
-
Tampere UniversityCompleted
-
Lyra Medical Ltd.CompletedAnterior Vaginal Wall Prolapse | Vaginal Apex/Uterine ProlapseHungary, Israel